Australian mental health staff response to antipsychotic medication side effects - the perceptions of consumers

Advances in Mental Health

Volumn 14, Issue 1, 2016, Pages 4-13

  Morrison, P ^a   Meehan, T ^b   Stomski, N J ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antipsychotic agents; Consumer participation; Interviews; Mental health; Qualitative research; Side effects

Indexed keywords

EID: 84962753784     PISSN: 18387357     EISSN: 18374905     Source Type: Journal    
DOI: 10.1080/18387357.2015.1080651     Document Type: Article

References (54)

1. Allen, M. H., Carpenter, D., Sheets, J. L., Miccio, S., & Ross, R. (2003). What do consumers say they want and need during a psychiatric emergency? Journal of Psychiatric Practice, 9, 39-58.
2. Australian Health Ministers. (1998). Second national mental health plan. Canberra: Commonwealth Department of Health and Family Services.
3. Australian Health Ministers. (2003). National mental health plan 2003-2008. Canberra: Australian Government.
4. Australian Human Rights Commission. (1993). National inquiry concerning the human rights of people with mental illness. Canberra: Australian Government Publishing Service.
5. Barr, J., & Threlkeld, A. J. (2000). Patient-practitioner collaboration in clinical decision-making. Physiotherapy Research International, 5, 254-260.
6. Bentall, R. P. (2010). Doctoring the mind: Why psychiatric treatments fail. London: Penguin.
7. Berg, B. (2009). Qualitative research methods for the social sciences (7th ed.). Boston, MA: Allyn & Bacon.
8. Borg, M., & Kristiansen, K. (2004). Recovery oriented professionals: Helping relationships in mental health services. Journal of Mental Health, 13, 493-505.
9. Burnard, P. (1996). Teaching the analysis of textual data: An experiential approach. Nurse Education Today, 16, 278-281.
10. Calsyn, R. J., Klinkenberg, W. D., Morse, G. A., & Lemming, M. R. (2006). Predictors of the working alliance in assertive community treatment. Community Mental Health Journal, 42, 161-175.
11. Carrick, R., Mitchell, A., Powell, R. A., & Lloyd, K. (2004). The quest for well-being: A qualitative study of the experience of taking antipsychotic medication. Psychology and Psychotherapy: Theory, Research and Practice, 77, 19-33.
12. Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Science & Medicine, 44, 681-692.
13. Commonwealth of Australia. (2012). Mental health statement of rights and responsibilities 2012. Canberra:Canberra Department of Health and Ageing.
14. De Leeuw, M., Van Meijel, B., Grypdonck, M., & Kroon, H. (2012). The quality of the working alliance between chronic psychiatric patients and their case managers: Process and outcomes. Journal of Psychiatric and Mental Health Nursing, 19, 1-7.
15. Ende, J., Kazis, L., Ash, A., & Moskowitz, M. A. (1989). Measuring patients’ desire for autonomy: Decision making and information-seeking preferences among medical patients. Journal of General Internal Medicine, 4, 23-30.
16. Gray, R., Wykes, T., & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277-284.
17. Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia:Challenges and management strategies. Patient Related Outcome Measures, 5, 43-62.
18. Halpern, J. (2003). Practicing medicine in the real world: Challenges to empathy and respect for patients. Journal of Clinical Ethics, 14, 298-307.
19. Hamer, H. P., Finlayson, M., & Warren, H. (2014). Insiders or outsiders? Mental health service users’ journeys towards full citizenship. International Journal of Mental Health Nursing, 23, 203-211.
20. Happell, B., Manias, E., & Roper, C. (2004). Wanting to be heard: Mental health consumers’ experiences of information about medication. International Journal of Mental Health Nursing, 13, 242-248.
21. Hartling, L., Abou-Setta, A. M., Dursun, S., Mousavi, S. S., Pasichnyk, D., & Newton, A. S. (2012). Antipsychotics in adults with schizophrenia: Comparative effectiveness of first-generation versus second-generation medications: A systematic review and meta-analysis. Annals of Internal Medicine, 157, 498-511.
22. Hon, A. (2012). Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: Findings from a grounded theory study. Journal of Psychiatric and Mental Health Nursing, 19, 354-361.
23. Kikkert, M. J., Schene, A. H., Koeter, M. W., Robson, D., Born, A., Helm, H., & Gray, R. J. (2006). Medication adherence in schizophrenia: Exploring patients’, carers’ and professionals’ views. Schizophrenia Bulletin, 32, 786-794.
24. Kvale, S., & Brinkmann, S. (2009). Interviews: Learning the craft of qualitative research interviewing (2nd ed.). Los Angeles: Sage.
25. Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009). How effective are secondgeneration antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14, 429-447.
26. Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus firstgeneration antipsychotic drugs for schizophrenia: A metaanalysis. Lancet, 373, 31-41.
27. Levinson, W., Lesser, C. S., & Epstein, R. M. (2010). Developing physician communication skills for patient-centered care. Health Affairs (Millwood), 29, 1310-1318.
28. McCabe, R., Heath, C., Burns, T., & Priebe, S. (2002). Engagement of patients with psychosis in the consultation:Conversation analytic study. British Medical Journal, 325, 1148-1151.
29. McCann, T. V., & Clark, E. (2004). Embodiment of severe and enduring mental illness: Finding meaning in schizophrenia. Issues in Mental Health Nursing, 25, 783-798.
30. Meehan, T., Stedman, T., & Wallace, J. (2011). Consumer strategies for coping with antipsychotic medication side effects. Australasian Psychiatry, 19, 74-77.
31. Moncrieff, J., & Leo, J. (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine, 40, 1409-1422.
32. Morrison, P., Gaskill, D., Meehan, T., Lunney, P., Lawrence, G., & Collings, P. (2000). The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. Australian and New Zealand Journal of Mental Health Nursing, 9, 166-176.
33. Morrison, P., Meehan, T., Gaskill, D., Lunney, P., & Collings, P. (2000). Enhancing case managers’ skills in the assessment and management of antipsychotic medication side-effects. Australian and New Zealand Journal of Psychiatry, 34, 814-821.
34. Morrison, P., Meehan, T., & Stomski, N. J. (2015a). Living with antipsychotic medication side effects:The experience of Australian mental health consumers. International Journal of Mental Health Nursing, 24, 253-261.
35. Morrison, P., Meehan, T., & Stomski, N. J. (2015b). Australian case managers’ perceptions of mental health consumers use of antipsychotic medications and associated side-effects. International Journal of Mental Health Nursing, 24, 104-111.
36. Morrison, P., & Stomski, N. J. (2015). Embracing participation in mental health research: Conducting authentic interviews. Qualitative Research Journal, 15, 47-60.
37. Naber, D., Karow, A., & Lambert, M. (2005). Subjective well-being under the neuroleptic treatment and its relevance for compliance. ActaPsychiatriac Scandinavica Supplement, 111, 29-34.
38. Neale, M. S., & Rosenheck, R. A. (2000). Therapeutic limit setting in an assertive community treatment program. Psychiatric Services, 51, 499-505.
39. Peluso, M. J., Lewis, S. W., Barnes, T. R., & Jones, P. B. (2012). Extrapyramidal motor side-effects of firstand second-generation antipsychotic drugs. British Journal of Psychiatry, 200, 387-392.
40. Prince, J. D. (2007). Therapeutic alliance, illness awareness, and number of hospitalizations for schizophrenia. Journal of Nervous and Mental Disorders, 195, 170-174.
41. Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360, 225-235.
42. Rogers, A., Day, J., Randall, F., & Bentall, R. P. (2003). Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication: A qualitative study. Social Psychiatry and Psychiatric Epidemiology, 38, 720-727.
43. Rogers, A., Day, J. C., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. P. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Social Science & Medicine, 47, 1313-1323.
44. Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., & Leucht, S. (2012). Second-generation antipsychotic drugs and extrapyramidal side effects: A systematic review and metaanalysis of head-to-head comparisons. Schizophrenia Bulletin, 38, 167-177.
45. Sajatovic, M., Jenkins, J. H., Cassidy, K. A., & Muzina, D. J. (2009). Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar disorder. Journal of Affective Disorders, 115, 360-366.
46. Salomon, C., & Hamilton, B. (2013). "All roads lead to medication?" Qualitative responses from an Australian first-person survey of antipsychotic discontinuation. Psychiaticr Rehabilitation Journal, 36, 160-165.
47. Schulze, B., & Angermeyer, M. C. (2003). Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Social Science & Medicine, 56, 299-312.
48. Seale, C., Chaplin, R., Lelliott, P., & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding:An observational study of psychiatric consultations. Social Science & Medicine, 65, 698-711.
49. Tranulis, C., Goff, D., Henderson, D. C., & Freudenreich, O. (2011). Becoming adherent to antipsychotics: A qualitative study of treatment-experienced schizophrenia patients. Psychiatric Services, 62, 888-892.
50. Tuohy, D., Cooney, A., Dowling, M., Murphy, K., & Sixsmith, J. (2013). An overview of interpretive phenomenology as a research methodology. Nurse Researcher, 20, 17-20.
51. Usher, K., Park, T., & Foster, K. (2013). The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective. Journal of Psychiatric and Mental Health Nursing, 20, 801-806.
52. Vandyk, A. D., & Baker, C. (2012). Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain. International Journal of Mental Health Nursing, 21, 349-357.
53. Ware, N. C., Tugenberg, T., & Dickey, B. (2004). Practitioner relationships and quality of care for lowincome persons with serious mental illness. Psychiatric Services, 55, 555-559.
54. Woltmann, E. M., & Whitley, R. (2010). Shared decision making in public mental health care: Perspectives from consumers living with severe mental illness. Psychiatric Rehabilitation Journal, 34, 29-36.